Rouquet N - Search Results

1

Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice.

Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Varlet P, Joulin V, Kahn A. Lacronique V, et al. Among authors: rouquet n. Nat Med. 1996 Jan;2(1):80-6. doi: 10.1038/nm0196-80. Nat Med. 1996. PMID: 8564847

2

Fas-dependent apoptosis is impaired by SV40 T-antigen in transgenic liver.

Rouquet N, Allemand I, Molina T, Bennoun M, Briand P, Joulin V. Rouquet N, et al. Oncogene. 1995 Sep 21;11(6):1061-7. Oncogene. 1995. PMID: 7566965

3

ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis.

Rouquet N, Pagès JC, Molina T, Briand P, Joulin V. Rouquet N, et al. Curr Biol. 1996 Sep 1;6(9):1192-5. doi: 10.1016/s0960-9822(02)70688-x. Curr Biol. 1996. PMID: 8805375 Free article.

4

Multiple pathways of Fas-induced apoptosis in primary culture of hepatocytes.

Rouquet N, Carlier K, Briand P, Wiels J, Joulin V. Rouquet N, et al. Biochem Biophys Res Commun. 1996 Dec 4;229(1):27-35. doi: 10.1006/bbrc.1996.1753. Biochem Biophys Res Commun. 1996. PMID: 8954079

5

LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.

Mignon A, Rouquet N, Fabre M, Martin S, Pagès JC, Dhainaut JF, Kahn A, Briand P, Joulin V. Mignon A, et al. Among authors: rouquet n. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1308-15. doi: 10.1164/ajrccm.159.4.9712012. Am J Respir Crit Care Med. 1999. PMID: 10194182

6

Protection of hepatocytes from Fas-mediated apoptosis by a non-transforming SV40 T-antigen mutant.

Rouquet N, Allemand I, Grimber G, Molina T, Briand P, Joulin V. Rouquet N, et al. Cell Death Differ. 1996 Jan;3(1):91-6. Cell Death Differ. 1996. PMID: 17180059

7

The influence of sintering temperature on the proliferation of fibroblastic cells in contact with HA-bioceramics.

Frayssinet P, Rouquet N, Fages J, Durand M, Vidalain PO, Bonel G. Frayssinet P, et al. Among authors: rouquet n. J Biomed Mater Res. 1997 Jun 5;35(3):337-47. doi: 10.1002/(sici)1097-4636(19970605)35:3<337::aid-jbm8>3.0.co;2-i. J Biomed Mater Res. 1997. PMID: 9138068

8

Osseointegration of macroporous calcium phosphate ceramics having a different chemical composition.

Frayssinet P, Trouillet JL, Rouquet N, Azimus E, Autefage A. Frayssinet P, et al. Among authors: rouquet n. Biomaterials. 1993 May;14(6):423-9. doi: 10.1016/0142-9612(93)90144-q. Biomaterials. 1993. PMID: 8507788

9

New observations on middle term hydroxyapatite-coated titanium alloy hip prostheses.

Frayssinet P, Hardy D, Rouquet N, Giammara B, Guilhem A, Hanker J. Frayssinet P, et al. Among authors: rouquet n. Biomaterials. 1992;13(10):668-74. doi: 10.1016/0142-9612(92)90126-9. Biomaterials. 1992. PMID: 1330016

10

Silver methenamine staining for scanning electron microscopy of bone sections containing biomaterials.

Frayssinet P, Hanker JS, Rouquet N, Primout I, Giammara B. Frayssinet P, et al. Among authors: rouquet n. Biotech Histochem. 1999 Jan;74(1):10-5. doi: 10.3109/10520299909066471. Biotech Histochem. 1999. PMID: 10190255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters